Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!
Trade Desk Inc (NASDAQ: TTD) stock soared nearly 30 percent early Friday morning in reaction to its first-quarter earnings report. The adtech company said it earned 34 cents per share in the quarter on revenue of $85.7 million versus estimates of 10 cents per share and $73.31 million. Management also guided its full-year 2018 revenue guidance to $433 million versus estimates of $403.96 million.
RXi Pharmaceuticals Corp (NASDAQ: RXII) gained more than 13 percent after announcing a new research collaboration. The immuno-oncology therapeutics company said it will partner with Iovance Biotherapeutics to evaluate the potential synergies with RXi's novel sd-rxRNA therapeutic compounds and Iovance's autologous cell therapy.
PowerShares Dynamic Pharmaceuticals(ETF) (NYSE: PJP) could see increased volatility throughout Friday's trading session. President Donald Trump is expected to deliver to the public his administration's vision on tackling drug prices.
Stellar Biotechnologies Inc (NASDAQ: SBOT) lost more than 40 percent early Friday morning. The low-float play stock has seen high volatility over the past few weeks and announced a new offering of 2.075 million shares of its common stock at $2.65 per unit. Shares of the therapeutic vaccine pipeline maker closed Thursday at $3.88.
MoSys Inc. (NASDAQ: MOSY) gained more than 40 percent in reaction to its first-quarter earnings beat on Thursday. The provider of semiconductor solutions said it earned 6 cents per share in the first quarter on revenue of $4.208 million versus expectations of a four cent per share loss and $3.95 million.
Related Links:
22 Stocks Moving In Friday's Pre-Market Session
A Peek Into The Markets: US Stock Futures Rise Ahead Of Import Prices, Consumer Sentiment Data
See more from Benzinga
JPMorgan Sends Beacon Roofing To The 'Penalty Box' After Q2 Miss
Bank Of America Upgrades Petrobras, Says Return To Financial Health Likely
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
